Viewing Study NCT00003092



Ignite Creation Date: 2024-05-05 @ 10:00 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003092
Status: COMPLETED
Last Update Posted: 2016-07-14
First Post: 1999-11-01

Brief Title: Paclitaxel in Treating Older Patients With Solid Tumors
Sponsor: Alliance for Clinical Trials in Oncology
Organization: Alliance for Clinical Trials in Oncology

Study Overview

Official Title: Clinical Pharmacology of Paclitaxel in Relation to Patient Age
Status: COMPLETED
Status Verified Date: 2016-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die

PURPOSE Phase III trial to study the effectiveness of paclitaxel in treating older patients who have solid tumors
Detailed Description: OBJECTIVES

Determine whether there is a relationship between pharmacokinetic measurements of paclitaxel and aging
Determine whether there is a relationship between the toxic effects of paclitaxel and aging

OUTLINE Patients are stratified according to age cohort 1 patients 55 to 64 vs cohort 2 patients 65 to 75 vs cohort 3 patients 75 and over

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
CDR0000065800 REGISTRY NCI Physician Data Query httpsreporternihgovquickSearchU10CA031946
U10CA031946 NIH None None
CLB-9762 None None None